JournalsHub
.online
Find My Journal
JR

Jeffrey V. Ravetch

Laboratory of Molecular Genetics PL

ORCID iD 0000-0003-2024-9041
389
Publications
61,694
Citations
126
H-Index
266
i10-Index
1.52
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells

Kevin Kao, N. Pihlstrom, Emily G Niejadlik, T. Cantaert, R. Ahmed - Proceedings of the National Academy of Sciences of the United States of America, 2025
Cited by 1 Semantic Scholar

982 Targeting glycans for cancer immunotherapy

J. Stark, Melissa A Gray, Itziar Ibarlucea-Benitez, M. Lustig, Annalise Bond - Regular and Young Investigator Award Abstracts, 2025
Cited by 0 Semantic Scholar

The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases

Diego E. Sastre, S. Bournazos, Maroš Huličiak, Barbara Ann C Grace, E. J. Boder - Nature Communications, 2025
Cited by 1 Semantic Scholar

Abstract CT086: Phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) therapy

Juan C. Osorio, Muneeb Alam, Jeffrey L. Wong, David A Knorr, Lucas Blanchard - Cancer Research, 2024
Cited by 0 Semantic Scholar

Tissue niche occupancy determines the contribution of fetal- versus bone-marrow-derived macrophages to IgG effector functions. OA

Miriam Wöhner, Sarah Brechtelsbauer, Niklas Friedrich, Christof Vorsatz, Johanna Bulang - Cell Reports, 2024
Cited by 6 Semantic Scholar

The anti-inflammatory activity of IgG requires the co-engagement of types I and II Fc receptors

Andrew T. Jones, T. Martynyuk, Alessandra Marino, S. Bournazos, J. Ravetch - bioRxiv, 2024
Cited by 2 Semantic Scholar

Antibody-lectin chimeras for glyco-immune checkpoint blockade OA

Jessica C. Stark, M. Gray, S. Wisnovsky, Itziar Ibarlucea-Benitez, M. Lustig - bioRxiv, 2024
Cited by 12 Semantic Scholar

MP16-17 PHASE I STUDY OF INTRAVESICAL FC-OPTIMIZED ANTI-CD40 AGONIST ANTIBODY 2141-V11 FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)

B. Bochner, Muneeb Alam, Juan C. Osorio, Jeffrey L. Wong, D. Knorr - Journal of Urology, 2024
Cited by 0 Semantic Scholar

Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody OA

Aaron Gupta, Kevin Kao, Rachel Yamin, D. Oren, Y. Goldgur - Nature Communications, 2023
Cited by 12 Semantic Scholar

Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia OA

Katherine Knorr, Jahan Rahman, C. Erickson, Eric Wang, Mara Monetti - Nature Cancer, 2023
Cited by 16 Semantic Scholar

Research Topics

Monoclonal and Polyclonal Antibodies Research (225) Glycosylation and Glycoproteins Research (128) T-cell and B-cell Immunology (107) Immune Cell Function and Interaction (87) Immunotherapy and Immune Responses (50)

Affiliations

The Wistar Institute
US 1989 - 1989
Scripps Research Institute
US 2008 - 2008
Kansai Medical University
JP 1999 - 1999
National Institutes of Health
US 1998 - 1981
Albert Einstein College of Medicine
US 1998 - 1998

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now